Cocrystal Pharma (COCP) Long-Term Deferred Tax (2015 - 2020)
Cocrystal Pharma (COCP) posted Long-Term Deferred Tax of $17.2 million for Q4 2020, up 11.9% sequentially from $15.4 million in Q4 2019, and up 11.9% YoY from $15.4 million in Q1 2020.
Cocrystal Pharma (COCP) Long-Term Deferred Tax (2015 - 2020) Analysis & Trends
Cocrystal Pharma has reported Long-Term Deferred Tax for 6 years, with the latest figure at $17.2 million in Q4 2020.
- Quarterly Long-Term Deferred Tax rose 11.9% year-over-year to $17.2 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $17.2 million (up 11.9% YoY) and the FY2020 annual result came in at $17.2 million, up 11.9% from the prior year.
- Long-Term Deferred Tax advanced to $17.2 million in Q4 2020 per COCP's latest filing, from $15.4 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $23.9 million in Q4 2016 and troughed at $1.5 million in Q3 2018.
- A 5-year average of $15.0 million and a median of $16.1 million in 2018 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2016 and 2017: Long-Term Deferred Tax surged 67.53% in 2016, then plunged 37.26% in 2017.
- Over 5 years, Long-Term Deferred Tax stood at $23.9 million in 2016, then slumped by 37.26% to $15.0 million in 2017, then grew by 12.3% to $16.8 million in 2018, then slipped by 8.56% to $15.4 million in 2019, then grew by 11.9% to $17.2 million in 2020.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $17.2 million, $15.4 million, and $16.8 million for Q4 2020, Q4 2019, and Q4 2018 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 17.24 Mn |
| Dec 31, 2019 | 15.41 Mn |
| Dec 31, 2018 | 16.85 Mn |
| Sep 30, 2018 | 1.46 Mn |
| Dec 31, 2017 | 15.00 Mn |
| Dec 31, 2016 | 23.91 Mn |
| Dec 31, 2015 | 14.27 Mn |